Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Neuronally differentiated macula densa cells regulate tissue remodeling and regeneration in the kidney
Georgina Gyarmati, … , Matthias Kretzler, János Peti-Peterdi
Georgina Gyarmati, … , Matthias Kretzler, János Peti-Peterdi
Published April 10, 2024
Citation Information: J Clin Invest. 2024;134(11):e174558. https://doi.org/10.1172/JCI174558.
View: Text | PDF
Research Article Nephrology

Neuronally differentiated macula densa cells regulate tissue remodeling and regeneration in the kidney

  • Text
  • PDF
Abstract

Tissue regeneration is limited in several organs, including the kidney, contributing to the high prevalence of kidney disease globally. However, evolutionary and physiological adaptive responses and the presence of renal progenitor cells suggest an existing remodeling capacity. This study uncovered endogenous tissue remodeling mechanisms in the kidney that were activated by the loss of body fluid and salt and regulated by a unique niche of a minority renal cell type called the macula densa (MD). Here, we identified neuronal differentiation features of MD cells that sense the local and systemic environment and secrete angiogenic, growth, and extracellular matrix remodeling factors, cytokines and chemokines, and control resident progenitor cells. Serial intravital imaging, MD nerve growth factor receptor and Wnt mouse models, and transcriptome analysis revealed cellular and molecular mechanisms of these MD functions. Human and therapeutic translation studies illustrated the clinical potential of MD factors, including CCN1, as a urinary biomarker and therapeutic target in chronic kidney disease. The concept that a neuronally differentiated key sensory and regulatory cell type responding to organ-specific physiological inputs controls local progenitors to remodel or repair tissues may be applicable to other organs and diverse tissue-regenerative therapeutic strategies.

Authors

Georgina Gyarmati, Urvi Nikhil Shroff, Anne Riquier-Brison, Dorinne Desposito, Wenjun Ju, Sean D. Stocker, Audrey Izuhara, Sachin Deepak, Alejandra Becerra Calderon, James L. Burford, Hiroyuki Kadoya, Ju-Young Moon, Yibu Chen, Markus M. Rinschen, Nariman Ahmadi, Lester Lau, Daniel Biemesderfer, Aaron W. James, Liliana Minichiello, Berislav V. Zlokovic, Inderbir S. Gill, Matthias Kretzler, János Peti-Peterdi

×

Figure 2

MD cell calcium signaling in vivo.

Options: View larger image (or click on image) Download as PowerPoint
MD cell calcium signaling in vivo.
(A) MPM imaging workflow to study 4D ...
(A) MPM imaging workflow to study 4D physiology in comparative (cc4DP), multicell (mc4DP), and single-cell (sc4DP) modes. Time-lapse recordings of same preparations are shown in Supplemental Video 2. (B) cc4DP mode using Sox2-GT mice. Left: Two-minute time-lapse maximum projection image (MPI) showing highest cumulative GCaMP5 (G5, green/yellow) fluorescence intensity (F) (reflecting cell Ca2+ elevations) in MD (green cells in attached glomerulus [G] drawing). Center: Comparison of G5F in single MD, juxtaglomerular (JG) renin, extra (EGM) and intraglomerular (IGM) mesangial cells, and afferent (AA) and efferent arteriole (EA) vascular smooth muscle cells, n = 4 (average of 5 cells/animal). Right: Time-lapse recordings of G5F normalized to baseline (F/F0) in MD (green), proximal tubule (PT, blue), and distal tubule (DT, purple) cells. (C) mc4DP mode using Sox2-GT mice. Left: Whole-MD pseudocolor MPI showing G5F heterogeneity between MD cells. Right: Simultaneous time-lapse recording of whole-MD G5F (green, smoothed) and AA diameter (magenta). (D) sc4DP mode using MD-GT mice. MD single cells show long axon-like processes (arrowhead, thick ascending limb [TAL] tubule fluid in gray scale) (left) and regular Ca2+ firing with 4-fold elevations in baseline (right). Scale bar: 20 μm. (E) MD single-cell G5F recordings in intact MD-GT mouse kidney in vivo and in vitro after isolation from freshly digested kidneys. (F) MD sc4DP responses to local/systemic stimuli. Left: MD cell Ca2+ firing frequency in control, low-salt diet (LS), and unilateral ureter obstruction (UUO). Center: Changes in MD G5F (baseline shown by dotted line) in response to systemically injected arginine-vasopressin (AVP), furosemide (Furo), gastrin, and in diabetes mellitus (DM). n = 6–8 (average of 4–5 cells/animal). Right: Time-lapse recording of whole-MD G5F during i.v. injection of the V1aR agonist arginine-vasopressin (AVP) given (indicated by red line) 2 minutes after recording baseline. Data represent mean ± SEM. **P < 0.01, ***P < 0.001, ****P < 0.0001, ANOVA followed by Dunnett’s test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts